武汉普渡生物医药有限公司致力于生物医药、医疗器械、食品及化妆品等领域提供全周期的临床研究服务，是同行业领先的CRO公司。公司汇聚跨学科的国际专家核心团队，业务范围涵盖I-Ⅳ期临床研究、真实世界研究、PK/PD建模与仿真、临床实施与监查、医学监查与评价、数据管理与统计分析、注册申报等。

基于临床药理、药代特点，设计创新药、改良型新药的试验方案，充分体现药物的临床优势与价值，形成差异化技术优势，助力创新药、改良型新药快速上市；基于生物药剂学，指导特殊制剂与复杂制剂处方工艺的改进，助力仿制药快速上市。

基于"方案设计-质量管理-风险控制"三位一体管理体系，将科学性与可行性、质量与风险管理贯穿临床试验全流程，确保项目快速有效实施、保障数据完整性和可溯源性。公司凭借科学严谨的临床方案设计能力、前瞻性的全流程风险预判机制、符合国际标准的执行体系，有效的为全球药品研发提供高效可靠的临床研究解决方案。

Wuhan Pudu Biomedical Co., Ltd. is a Contract Research Organization (CRO) dedicated to providing full-cycle clinical research services for the biomedical, medical device, food, and cosmetics industries. Centered around an interdisciplinary international team of experts, the company's services encompass Phase I-IV clinical trials, real-world research, PK/PD modeling and simulation, clinical implementation and monitoring, medical evaluation, data management, statistical analysis and registration declaration.
Leveraging clinical pharmacology and pharmacokinetics, we design protocols for innovative drugs and improved new drugs to fully demonstrate their clinical advantages and characteristics. This approach establishes differentiated technical advantages, facilitating rapid market entry for these therapeutics. Additionally, based on biopharmaceutics principles, we guide the optimization of formulation processes for specialized and complex drug products, accelerating the commercialization of generic drugs.

Building upon our trinity management framework of "Protocol Design – Quality Management – Risk Control", we systematically integrate quality assessment and proactive risk anticipation throughout the entire clinical trial lifecycle. This ensures robust data integrity and full traceability. With demonstrated strengths in scientific protocol design, forward-looking end-to-end risk prediction mechanisms, and internationally compliant execution systems, we deliver efficient and reliable clinical research solutions to accelerate global drug development programs.